Uncategorized

Introduction Inclisiran is another therapeutic agent that exerts its effect by interfering with the PCSK9 molecule, not by inhibiting its action but by inhibiting its production inside the cytoplasm. Inclisiran uses the body’s naturally occurring machinery called RNA Interference (RNAi)… Read More »Inclisiran: From RNA Interference (RNAi) to Cholesterol Management

Introduction PCSK9, or Proprotein Convertase Subtilisin/Kexin type 9, is a molecule that has gained a significant role in cardiovascular health and cholesterol management in recent years. First discovered in 2003, this protein plays a crucial role in cholesterol metabolism in… Read More »PCSK9 Inhibitors: The New Frontier in Cholesterol Management

Bempedoic Acid | Introduction and Video https://youtu.be/Q70VY2m3bz8 Video: Bempedoic Acid mechanism of action Bempedoic acid is a novel treatment against hypercholesterolemia. It offers hope to patients struggling to control their cholesterol levels, mainly when traditional therapies fall short or cause… Read More »Bempedoic Acid